Accord Research   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Prague Czech Republic (1991)

Organization Overview

First Clinical Trial
2012
NCT02105675
First Marketed Drug
1991
cyanocobalamin (berocca)
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

ACCORD HLTHCARE | ACCORD HLTHCARE INC | Sotio Accord | Sotio-Accord | Sotio as | Sotio a.s. | SOTIO Biotech | SOTIO, LLC